These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 17150545)

  • 1. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
    Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
    Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
    Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
    J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
    Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
    Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
    Dahl G; Sandström A; Akerblom E; Danielson UH
    Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RNA aptamer-binding site of hepatitis C virus NS3 protease.
    Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Shimotohno K; Taira K; Kusakabe I; Nishikawa S
    Biochem Biophys Res Commun; 2000 Dec; 279(2):557-62. PubMed ID: 11118325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins.
    Massariol MJ; Zhao S; Marquis M; Thibeault D; White PW
    Biochem Biophys Res Commun; 2010 Jan; 391(1):692-7. PubMed ID: 19944069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis C virus RNA replicons by peptide aptamers.
    Trahtenherts A; Gal-Tanamy M; Zemel R; Bachmatov L; Loewenstein S; Tur-Kaspa R; Benhar I
    Antiviral Res; 2008 Mar; 77(3):195-205. PubMed ID: 18243349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.
    Kumar PK; Machida K; Urvil PT; Kakiuchi N; Vishnuvardhan D; Shimotohno K; Taira K; Nishikawa S
    Virology; 1997 Oct; 237(2):270-82. PubMed ID: 9356339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of HCV protease inhibitors.
    Chen KX; Njoroge FG
    Curr Opin Investig Drugs; 2009 Aug; 10(8):821-37. PubMed ID: 19649927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
    Nishikawa F; Funaji K; Fukuda K; Nishikawa S
    Oligonucleotides; 2004; 14(2):114-29. PubMed ID: 15294075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.
    Maga G; Gemma S; Fattorusso C; Locatelli GA; Butini S; Persico M; Kukreja G; Romano MP; Chiasserini L; Savini L; Novellino E; Nacci V; Spadari S; Campiani G
    Biochemistry; 2005 Jul; 44(28):9637-44. PubMed ID: 16008349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.
    Hwang B; Cho JS; Yeo HJ; Kim JH; Chung KM; Han K; Jang SK; Lee SW
    RNA; 2004 Aug; 10(8):1277-90. PubMed ID: 15247433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific RNA aptamers to NS3 protease domain of hepatitis C virus.
    Fukuda K; Vishinuvardhan D; Sekiya S; Kakiuchi N; Shimotohno K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1997; (37):237-8. PubMed ID: 9586087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.
    Stankiewicz-Drogoń A; Dörner B; Erker T; Boguszewska-Chachulska AM
    J Med Chem; 2010 Apr; 53(8):3117-26. PubMed ID: 20337460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
    Liu D; Wang YS; Gesell JJ; Wyss DF
    J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
    Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
    Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
    Kuang WF; Lin YC; Jean F; Huang YW; Tai CL; Chen DS; Chen PJ; Hwang LH
    Biochem Biophys Res Commun; 2004 Apr; 317(1):211-7. PubMed ID: 15047170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virus helicase.
    Chen CS; Chiou CT; Chen GS; Chen SC; Hu CY; Chi WK; Chu YD; Hwang LH; Chen PJ; Chen DS; Liaw SH; Chern JW
    J Med Chem; 2009 May; 52(9):2716-23. PubMed ID: 19419203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
    Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.